6 Risperdal Suits To See Appeal Over Marketers' Dismissal

Law360, Philadelphia (November 16, 2012, 6:45 PM EST) -- An attorney representing six men who allegedly grew breasts after taking the antipsychotic Risperdal said Friday he would appeal a Pennsylvania judge’s ruling in favor of two marketing firms that allegedly assisted Johnson & Johnson in pushing the medicine for off-label use in children.

Brian J. McCormick Jr., a Sheller PC attorney representing dozens of plaintiffs who claim they grew breasts as a side effect of taking Risperdal, told Law360 on Friday that appeals were planned for six cases in which Excerpta Medica Inc. and Elsevier...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.